Edition:
United States

Marrone Bio Innovations Inc (MBII.OQ)

MBII.OQ on NASDAQ Stock Exchange Capital Market

1.81USD
12:35pm EDT
Change (% chg)

$0.02 (+1.12%)
Prev Close
$1.79
Open
$1.86
Day's High
$1.86
Day's Low
$1.81
Volume
19,382
Avg. Vol
138,154
52-wk High
$3.39
52-wk Low
$0.86

Chart for

About

Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company's bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate... (more)

Overall

Beta: -0.48
Market Cap(Mil.): $182.75
Shares Outstanding(Mil.): 102.09
Dividend: --
Yield (%): --

Financials

  MBII.OQ Industry Sector
P/E (TTM): -- 26.69 32.97
EPS (TTM): -0.80 -- --
ROI: -86.19 1.79 7.36
ROE: -- 2.98 9.81

BRIEF-Marrone Bio Innovations Q1 Revenue $4.3 Million Versus $4.2 Million

* MARRONE BIO INNOVATIONS, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 10 2018

BRIEF-Evogene And Marrone Bio Innovations Announce Phase Advancement In Their Insect Control Collaboration

* EVOGENE AND MARRONE BIO INNOVATIONS ANNOUNCE PHASE ADVANCEMENT IN THEIR INSECT CONTROL COLLABORATION

May 08 2018

BRIEF-Marrone Bio Innovations Appoints Kevin Hammill As New Chief Commercial Officer

* MARRONE BIO INNOVATIONS APPOINTS KEVIN HAMMILL AS NEW CHIEF COMMERCIAL OFFICER Source text for Eikon: Further company coverage:

May 07 2018

BRIEF-Marrone Bio Innovations And Lidorr Chemicals Sign Distribution Agreement In Israel

* MARRONE BIO INNOVATIONS AND LIDORR CHEMICALS LTD. SIGN DISTRIBUTION AGREEMENT IN ISRAEL

Apr 25 2018

BRIEF-Marrone Bio Innovations Announces Proposed Public Offering Of Common Stock

* MARRONE BIO INNOVATIONS, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

Apr 17 2018

BRIEF-Marrone Bio Innovations Files Prospectus Relates To Offering Of Up To 119 Mln Shares Of Co's Common Stock By Selling Stockholders

* Marrone Bio Innovations Files Prospectus Relates To Offering Of Up To 119 Mln Shares Of Co's Common Stock By Selling Stockholders - SEC Filing Source text (https://bit.ly/2IDKFzU) Further company coverage:

Apr 09 2018

BRIEF-Marrone Bio Innovations Inc Files For Non-Timely 10-K With U.S. SEC

* MARRONE BIO INNOVATIONS INC FILES FOR NON-TIMELY 10-K WITH U.S. SEC Source text: (https://bit.ly/2uJc15x) Further company coverage:

Apr 03 2018

BRIEF-Marrone Bio Innovations Says Q4 Revenue Rose 23.3 Pct To $3.3 Mln

* MARRONE BIO INNOVATIONS, INC. REPORTS RECORD FULL YEAR 2017 FINANCIAL RESULTS

Mar 29 2018

BRIEF-Marrone Bio Innovations Signs Distribution Agreement With Solenis

* MARRONE BIO INNOVATIONS - SIGNS DISTRIBUTION AGREEMENT WITH SOLENIS TO PROVIDE ZEQUANOX MOLLUSCICIDE TREATMENT PROGRAMS FOR WATER SYSTEMS IN U.S., CANADA Source text for Eikon: Further company coverage:

Mar 15 2018

Earnings vs. Estimates